Did Nicholas Taylor sell Regeneron Pharmaceuticals stock?

Common questions

Did Nicholas Taylor sell Regeneron Pharmaceuticals stock?

Yes. Nicholas Taylor disclosed 2 sales of Regeneron Pharmaceuticals (REGN) stock between Jan 22, 2019 and Feb 6, 2019, in STOCK Act reports. Added together, the disclosed ranges come to $2K-$30K.

How big were Nicholas Taylor's Regeneron Pharmaceuticals trades?

STOCK Act reports give a range for each trade, such as $1K-$15K, never an exact amount. Added together, the disclosed ranges come to $2K-$30K.

Did Nicholas Taylor make these Regeneron Pharmaceuticals trades personally?

Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.

Does Nicholas Taylor still own Regeneron Pharmaceuticals stock?

This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.

When did Nicholas Taylor report these trades?

The latest filing is dated Mar 14, 2019. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.

Where does this data come from?

From periodic transaction reports filed under the STOCK Act with the Clerk of the House. Every trade links to the original filing.